Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.
Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage version updated from v3.3.1 to v3.3.2. No substantive changes to study details, eligibility, or results are visible.SummaryDifference0.1%
- Check21 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check29 days agoChange DetectedThe funding/operating status notice shown on the NIH site was removed. This notice was not part of the study details and does not alter the trial information (eligibility, endpoints, or results). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check43 days agoChange DetectedThe screenshots show no additions or deletions to the page content; the study details page appears unchanged.SummaryDifference0.4%
- Check71 days agoChange DetectedMajor update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.SummaryDifference3%
- Check79 days agoChange DetectedUpdated the page's revision from v3.0.2 to v3.1.0, indicating a new release/version without changing core content or pricing.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.